Does Transcutaneous Phrenic Nerve Stimulation Prevent Diaphragm Atrophy?
Recruiting
Observational Study
Critical Care, Intensive Care
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 80 (estimated)
- Sponsor
- Bakirkoy Dr. Sadi Konuk Research and Training Hospital · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Dear participant Participants's patient, who is participants's first-degree relative, who is connected to a ventilator in the intensive care unit, unconscious and not authorized to give informed consent, has been invited to participate in the study titled 'Does transcutaneous phrenic nerve stimulation prevent diaphragm atrophy?
In order to strengthen this muscle and prevent loss of function, inve…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:Patients on invasive mechanical ventilation for 72 hours or more Patients older than 18 years
Exclusion Criteria: Patients under 18 years of age
* Patients with less than 72 hours of mechanical ventilation
* Pregnancy
* Patients with a body mass index above 35kg/m²
* Neuromuscul…
Contacts